IVF_INSPIRE IVF

Inspire IVF Public Company Limited, or IVF, has acquired a 24% stake in Eternity Healthcare 369 Company Limited, or ETERNITY, and the two parties have begun discussing avenues for cooperation and are preparing cross-selling to connect their customer bases and expand joint business opportunities. Kesinee Kuldilok, Chief Executive Officer of IVF, said the partnership will reinforce the strengths of both sides, since ETERNITY specialises in men's health, particularly Urology, while IVF is strong in women's health and fertility treatment, covering egg freezing, IVF and ICSI, allowing the two to extend their health services to cover both women and men more comprehensively. The company has also expanded its services under Inspire IVF in the Wellness segment, which officially opened for service early last month on the G floor of the Ploenchit Center building, while the IVF centre is located on the 5th floor of the same building. The Wellness services cover vitamin infusions, blood tests, screening for 10 types of cancer, cell age testing and Hyperbaric Oxygen Therapy, targeting premium customers, who are currently mostly foreign clients, especially from the Middle East, whose per-capita spending is higher than that of Thai customers. For its second-half 2026 plan, the company will continue to market its IVF business, and in about two weeks it is preparing to market and hold roadshows in India in both B2B and B2C formats, bringing a team of doctors along to provide consultations, while in October it plans to travel to China to tap the B2B segment further, alongside driving the Wellness business and building synergies with ETERNITY.

Inspire IVF Public Company Limited (IVF) has announced the use of LUNA Robotics robots to present information to investors at the Opp Day event, marking the first time in Thailand. The robot will present data on behalf of executives, while the CEO and CFO will only handle Q&A sessions. The company plans to pilot the robot at a new branch within three months and collaborate with partner hospitals that do not yet offer IVF services to reduce personnel costs and promote its services. Additionally, IVF has established a subsidiary named M22 Company Limited (M22) to expand into the non-healthcare sector and has held discussions with UBTECH Robotics (UBT), a major Chinese humanoid robot company listed on the Hong Kong Stock Exchange in December 2023, with the goal of developing a platform for selling robots and AI to external organizations in the future.

BIZ, a new-era health company, has launched BIZGENES, a Thai brand for precision health and longevity solutions, at the BIZGENES Brand Launch and Medical Symposium 2026, inviting Thais to start by understanding themselves. Executives say the brand builds on over 26 years of expertise, and they introduced The Vitality Collection under the concept of science-based nutrition, so Thais can make appropriate health decisions at every stage of life. Meanwhile, the IVF arm is making a major strategic move to build a healthcare ecosystem by acquiring a 24 percent stake in Eternity Healthcare 369, a leading Thai specialty clinic in urological surgery and men's health. This is expected to drive company growth of at least 15 percent and a net profit margin of 12 percent, in line with targets.

Inspire IVF Public Company Limited, or IVF, has acquired a 24% stake in Eternity Healthcare 369 Company Limited, or ETERNITY, a specialist clinic in urology and men's sexual health, with a total investment of up to 140.40 million baht. The move aims to build a healthcare ecosystem and expand into the men's health market, which is valued at approximately 25 billion baht, targeting a 2% market share. This partnership will enable IVF to reach premium customers from the Middle East who travel to Thailand for services, and is expected to help drive revenue growth of at least 15% in 2026, with a net profit margin of 12%. Meanwhile, ETERNITY plans to expand to 14 to 15 branches within three years and will jointly establish Thailand's first men's sexual health hospital within the next two months, catering to the confidence of foreign customers who prefer receiving services in a hospital setting rather than a clinic.